All clinical trials require planning, execution and well-trained resources. But when it comes to respiratory diseases such as asthma, COPD and idiopathic pulmonary fibrosis, experience and knowledge of the therapeutic area and of specialized tests such as spirometry, body plethysmography and lung diffusion capacity are required to manage the disease.
Studies in respiratory diseases such as asthma and COPD may be complex, logistically difficult to execute and require experienced sites and study monitors. OPIS has years of experience and broad expertise across a wide range of respiratory indications.
More than 60 studies managed
Indications: allergic rhinoconjunctivitis, asthma, chronic obstructive pulmonary disease, eosinophilic asthma, idiopathic pulmonary fibrosis, lymphangioleiomyomatosis, pulmonary arterial hypertension, pulmonary oedema
Phases: II, IIa, IIb, III, IIIb, IV
Other details: interventional and non-interventional studies in adult and children